Astrazeneca Plc (AZN) Holding Boosted by Johnston Asset Management Corp; As Ansys (ANSS) Valuation Declined, Shareholder Pitcairn Company Has Trimmed Position

AstraZeneca PLC (NYSE:AZN) Logo

Johnston Asset Management Corp increased its stake in Astrazeneca Plc (AZN) by 8.64% based on its latest 2018Q3 regulatory filing with the SEC. Johnston Asset Management Corp bought 106,320 shares as the company’s stock rose 1.75% while stock markets declined. The institutional investor held 1.34 million shares of the major pharmaceuticals company at the end of 2018Q3, valued at $52.92 million, up from 1.23M at the end of the previous reported quarter. Johnston Asset Management Corp who had been investing in Astrazeneca Plc for a number of months, seems to be bullish on the $93.41B market cap company. The stock decreased 1.67% or $0.62 during the last trading session, reaching $36.58. About 4.39M shares traded. AstraZeneca PLC (NYSE:AZN) has risen 19.21% since February 13, 2018 and is uptrending. It has outperformed by 19.21% the S&P500. Some Historical AZN News: 03/04/2018 – GERMANY’S IQWIG SEES NO ADDL BENEFIT IN DAPAGLIFLOZIN+METFORMIN; 24/04/2018 – ASTRAZENECA PLC AZN.L – ASTRAZENECA REPORTS RESULTS FROM ARCTIC TRIAL IN THIRD-LINE NON-SMALL CELL LUNG CANCER; 10/05/2018 – GENENTECH- RESULTS FROM IMBLAZE370 SHOWED TREATMENT WITH TECENTRIQ ALONE DID NOT PROVIDE MEANINGFUL CLINICAL BENEFIT COMPARED TO REGORAFENIB; 11/04/2018 – newsbox.ch/ Molecular Partners and AstraZeneca announce collaboration on Molecular Partners’ ongoing oncology clinical study with MP0250 in EGFR-mutated NSCLC; 03/04/2018 – MERCK & CO INC – MAA IS BASED ON DATA FROM RANDOMIZED, OPEN-LABEL, PHASE 3 OLYMPIAD TRIAL, WHICH INVESTIGATED LYNPARZA VERSUS CHEMOTHERAPY; 21/05/2018 – lnovio Opens Phase 2 Trial for VGX-3100 in Third lndication To Treat HPV — The No. 1 Sexually Transmitted Disease; 21/05/2018 – ASTRAZENECA AZ REGULATORY SUBMISSION IN JAPAN FOR FORXIGA; 03/04/2018 – US FDA ACCEPTS BIOLOGICS LICENSE APPLICATION FOR MOXETUMOMAB PA; 22/03/2018 – ASTRAZENECA LOKELMA APPROVED IN EU FOR W/ HYPERKALAEMIA; 21/05/2018 – U.K.’S FTSE 100 RISES 0.4%; ASTRAZENECA PLC GAINS

Pitcairn Company decreased its stake in Ansys Inc (ANSS) by 49.25% based on its latest 2018Q3 regulatory filing with the SEC. Pitcairn Company sold 6,398 shares as the company’s stock declined 16.81% with the market. The institutional investor held 6,592 shares of the technology company at the end of 2018Q3, valued at $1.23 million, down from 12,990 at the end of the previous reported quarter. Pitcairn Company who had been investing in Ansys Inc for a number of months, seems to be less bullish one the $14.47B market cap company. The stock decreased 1.09% or $1.9 during the last trading session, reaching $173.11. About 401,379 shares traded. ANSYS, Inc. (NASDAQ:ANSS) has risen 5.52% since February 13, 2018 and is uptrending. It has outperformed by 5.52% the S&P500. Some Historical ANSS News: 30/05/2018 – Ansys Presenting at Berenberg Design Software Conference Jun 13; 02/05/2018 – Ansys Sees 2Q EPS 54c-EPS 76c; 15/05/2018 – A SORIANO CORP ANS.PS – QTRLY GROSS REVENUE 2.51 BLN PESOS VS 3.92 BLN PESOS; 02/05/2018 – Ansys 1Q Net $84.3M; 02/05/2018 – Ansys Sees FY EPS $3.29-EPS $3.94; 04/05/2018 – ANSYS INC ANSS.O : WEDBUSH RAISES TARGET PRICE TO $163 FROM $160; 02/05/2018 – ANSYS BUYS OPTIS, BECOMES INDUSTRY’S LEADING SOLUTION PROVIDER; 26/04/2018 – Penguin Computing Named an ANSYS Advanced Solutions Partner; 25/04/2018 – SOUTH AFRICA’S COMPETITION COMMISSION – HAS APPROVED PROPOSED MERGER, WITHOUT CONDITIONS, WHEREBY ANSYS INTENDS TO ACQUIRE LAW TRUST; 02/05/2018 – Ansys Sees 2Q Rev $269.5M-$289.5M

Analysts await ANSYS, Inc. (NASDAQ:ANSS) to report earnings on February, 20. They expect $1.33 earnings per share, up 37.11% or $0.36 from last year’s $0.97 per share. ANSS’s profit will be $111.13M for 32.54 P/E if the $1.33 EPS becomes a reality. After $1.10 actual earnings per share reported by ANSYS, Inc. for the previous quarter, Wall Street now forecasts 20.91% EPS growth.

Since August 22, 2018, it had 0 insider purchases, and 6 selling transactions for $4.66 million activity. Emswiler Shane sold 3,511 shares worth $657,224. 2,454 shares valued at $461,327 were sold by SCHERER BARBARA VAUGHN on Thursday, September 13. GALLIMORE ALEC D. sold $47,958 worth of stock. THURK MICHAEL also sold $532,894 worth of ANSYS, Inc. (NASDAQ:ANSS) shares. $1.17 million worth of stock was sold by MAHONEY RICHARD S. on Thursday, January 3.

Among 19 analysts covering Ansys Inc. (NASDAQ:ANSS), 9 have Buy rating, 2 Sell and 8 Hold. Therefore 47% are positive. Ansys Inc. had 47 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of ANSYS, Inc. (NASDAQ:ANSS) earned “Equal-Weight” rating by Barclays Capital on Friday, August 5. The rating was upgraded by Wedbush on Friday, November 2 to “Outperform”. The firm has “Buy” rating by Robert W. Baird given on Monday, August 28. As per Friday, January 6, the company rating was downgraded by Barclays Capital. The stock of ANSYS, Inc. (NASDAQ:ANSS) has “Buy” rating given on Wednesday, June 20 by Goldman Sachs. The firm earned “Hold” rating on Thursday, September 15 by Evercore. The firm earned “Hold” rating on Thursday, August 3 by RBC Capital Markets. Robert W. Baird maintained it with “Buy” rating and $19700 target in Monday, June 25 report. As per Friday, November 3, the company rating was maintained by RBC Capital Markets. The rating was maintained by Berenberg on Friday, May 4 with “Buy”.

Investors sentiment increased to 1.02 in 2018 Q3. Its up 0.08, from 0.94 in 2018Q2. It improved, as 28 investors sold ANSS shares while 167 reduced holdings. 62 funds opened positions while 136 raised stakes. 75.82 million shares or 2.51% less from 77.77 million shares in 2018Q2 were reported. Brown Cap Mngmt Ltd Liability holds 2.39M shares or 4.05% of its portfolio. Fdx Advsr Inc reported 13,121 shares or 0.09% of all its holdings. 14 were reported by San Francisco Sentry Investment Grp (Ca). Landscape Mgmt reported 3,514 shares or 0.05% of all its holdings. Livforsakringsbolaget Skandia Omsesidigt, a Sweden-based fund reported 706 shares. 92,597 were reported by Trillium Asset Mngmt Limited Liability. Teachers Retirement Systems Of The State Of Kentucky owns 7,950 shares for 0.02% of their portfolio. New York State Common Retirement Fund reported 456,139 shares. The California-based Laurel Grove Capital Ltd Co has invested 0.31% in ANSYS, Inc. (NASDAQ:ANSS). Css Ltd Il invested in 0.03% or 3,850 shares. Cibc Asset Mgmt reported 0.01% in ANSYS, Inc. (NASDAQ:ANSS). Da Davidson And has 0.01% invested in ANSYS, Inc. (NASDAQ:ANSS) for 2,638 shares. Teacher Retirement Of Texas reported 0.04% of its portfolio in ANSYS, Inc. (NASDAQ:ANSS). 184 are held by Ledyard Commercial Bank. Mendel Money reported 27,892 shares.

Pitcairn Company, which manages about $964.40M US Long portfolio, upped its stake in Marathon Pete Corp (NYSE:MPC) by 5,363 shares to 21,741 shares, valued at $1.74M in 2018Q3, according to the filing. It also increased its holding in Ecolab Inc (NYSE:ECL) by 2,749 shares in the quarter, for a total of 7,445 shares, and has risen its stake in Amgen Inc (NASDAQ:AMGN).

More notable recent ANSYS, Inc. (NASDAQ:ANSS) news were published by: Nasdaq.com which released: “ANSS Makes Bullish Cross Above Critical Moving Average – Nasdaq” on February 01, 2019, also Nasdaq.com with their article: “All You Need to Know About Ansys (ANSS) Rating Upgrade to Buy – Nasdaq” published on February 07, 2019, Prnewswire.com published: “Newly Launched ANSYS Cloud Accelerates Engineering Productivity and Business Agility – PRNewswire” on February 05, 2019. More interesting news about ANSYS, Inc. (NASDAQ:ANSS) were released by: Nasdaq.com and their article: “PTC Q1 Earnings Surpass Estimates, Revenues Increase Y/Y – Nasdaq” published on January 24, 2019 as well as Globenewswire.com‘s news article titled: “ANSYS to Release Fourth Quarter and FY 2018 Earnings on February 27, 2019 – GlobeNewswire” with publication date: January 28, 2019.

Johnston Asset Management Corp, which manages about $4.21 billion and $2.32B US Long portfolio, decreased its stake in Microsoft Corp (NASDAQ:MSFT) by 4,870 shares to 380,302 shares, valued at $43.50 million in 2018Q3, according to the filing. It also reduced its holding in Stanley Black & Decker Inc (NYSE:SWK) by 84,410 shares in the quarter, leaving it with 148,175 shares, and cut its stake in Adobe Sys Inc (NASDAQ:ADBE).

Among 29 analysts covering AstraZeneca plc (ADR) (NYSE:AZN), 16 have Buy rating, 1 Sell and 12 Hold. Therefore 55% are positive. AstraZeneca plc (ADR) had 51 analyst reports since July 31, 2015 according to SRatingsIntel. Bernstein maintained AstraZeneca PLC (NYSE:AZN) on Monday, February 5 with “Buy” rating. The firm has “Outperform” rating given on Friday, December 9 by Leerink Swann. As per Monday, November 2, the company rating was downgraded by Nordea. On Friday, September 22 the stock rating was upgraded by Bernstein to “Outperform”. On Friday, July 28 the stock rating was downgraded by Morgan Stanley to “Equal-Weight”. The stock of AstraZeneca PLC (NYSE:AZN) has “Overweight” rating given on Friday, September 23 by Piperjaffray. Deutsche Bank upgraded the shares of AZN in report on Monday, September 14 to “Buy” rating. The firm has “Hold” rating by Jefferies given on Tuesday, March 15. Citigroup maintained AstraZeneca PLC (NYSE:AZN) on Wednesday, October 18 with “Buy” rating. On Friday, May 12 the stock rating was upgraded by Credit Suisse to “Neutral”.

More notable recent AstraZeneca PLC (NYSE:AZN) news were published by: Seekingalpha.com which released: “AstraZeneca’s MEDI8897 nabs accelerated review status in U.S. and Europe – Seeking Alpha” on February 05, 2019, also Seekingalpha.com with their article: “European advisory group backs AstraZeneca’s Forxiga in T1D – Seeking Alpha” published on February 01, 2019, 247Wallst.com published: “Top Analyst Upgrades and Downgrades: Avaya, AstraZeneca, HD Supply, HubSpot, Intel, Norfolk Southern, Ultimate Software, Valero Energy and More – 24/7 Wall St.” on January 25, 2019. More interesting news about AstraZeneca PLC (NYSE:AZN) were released by: Seekingalpha.com and their article: “AstraZeneca to promote Luye Pharma cholesterol med in China – Seeking Alpha” published on January 16, 2019 as well as Fool.com‘s news article titled: “Here’s Why Moderna Jumped 9.7% on Thursday – Motley Fool” with publication date: January 31, 2019.

ANSYS, Inc. (NASDAQ:ANSS) Ratings Chart